Prolonged presence of VEGF promotes vascularization in 3D bioprinted scaffolds with defined architecture

Journal of Controlled Release

Volumn 184, Issue 1, 2014, Pages 58-66

  Poldervaart, Michelle T ^a   Gremmels, Hendrik ^a   Van Deventer, Kelly ^a   Fledderus, Joost O ^a   Öner, F Cumhur ^a   Verhaar, Marianne C ^a   Dhert, Wouter J A ^a,b   Alblas, Jacqueline ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

3D printing; Bioprinting; Gelatin microparticles; Regenerative medicine; Vascularization; VEGF

Indexed keywords

BIOACTIVITY; MAMMALS; REGENERATIVE MEDICINE;

3-D PRINTING; BIOPRINTING; GELATIN MICROPARTICLES; VASCULARIZATION; VEGF;

3D PRINTERS;

CD133 ANTIGEN; CD14 ANTIGEN; CD31 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; ENDOGLIN; GELATIN; MATRIGEL; THY 1 ANTIGEN; VASCULOTROPIN; VASCULOTROPIN A;

ARTICLE; BIOPRINTING; CELL MIGRATION; CONTROLLED STUDY; ENDOTHELIAL PROGENITOR CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; PRIORITY JOURNAL; SUSTAINED DRUG RELEASE; UMBILICAL CORD BLOOD; VASCULARIZATION; ANGIOGENESIS; ANIMAL; CELL MOTION; CHEMISTRY; DRUG EFFECTS; FEMALE; NUDE MOUSE; PHYSIOLOGY; THREE DIMENSIONAL PRINTING; TISSUE SCAFFOLD;

ANIMALS; CELL MOVEMENT; ENDOTHELIAL PROGENITOR CELLS; FEMALE; GELATIN; HUMANS; MICE, NUDE; NEOVASCULARIZATION, PHYSIOLOGIC; PRINTING, THREE-DIMENSIONAL; TISSUE SCAFFOLDS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84899800867     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2014.04.007     Document Type: Article

References (39)

1. S. Levenberg, J. Rouwkema, M. Macdonald, E.S. Garfein, D.S. Kohane, D.C. Darland, R. Marini, C.A. van Blitterswijk, R.C. Mulligan, P.A. D'Amore, and R. Langer Engineering vascularized skeletal muscle tissue Nat. Biotechnol. 23 2005 879 884
2. M.W. Laschke, Y. Harder, M. Amon, I. Martin, J. Farhadi, A. Ring, N. Torio-Padron, R. Schramm, M. Rucker, D. Junker, J.M. Haufel, C. Carvalho, M. Heberer, G. Germann, B. Vollmar, and M.D. Menger Angiogenesis in tissue engineering: breathing life into constructed tissue substitutes Tissue Eng. 12 2006 2093 2104
3. T. Asahara, T. Takahashi, H. Masuda, C. Kalka, D. Chen, H. Iwaguro, Y. Inai, M. Silver, and J.M. Isner VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells EMBO J. 18 1999 3964 3972
4. D.A. Ingram, N.M. Caplice, and M.C. Yoder Unresolved questions, changing definitions, and novel paradigms for defining endothelial progenitor cells Blood 106 2005 1525 1531
5. H. Gremmels, J.O. Fledderus, B.W. van Balkom, and M.C. Verhaar Transcriptome analysis in endothelial progenitor cell biology Antioxid. Redox Signal. 15 2011 1029 1042
6. M.C. Yoder, L.E. Mead, D. Prater, T.R. Krier, K.N. Mroueh, F. Li, R. Krasich, C.J. Temm, J.T. Prchal, and D.A. Ingram Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals Blood 109 2007 1801 1809
7. P.J. Critser, and M.C. Yoder Endothelial colony-forming cell role in neoangiogenesis and tissue repair Curr. Opin. Organ Transplant. 15 2010 68 72
8. M.I. Santos, and R.L. Reis Vascularization in bone tissue engineering: physiology, current strategies, major hurdles and future challenges Macromol. Biosci. 10 2010 12 27
9. N. Ferrara, H.P. Gerber, and J. LeCouter The biology of VEGF and its receptors Nat. Med. 9 2003 669 676
10. S.M. Eppler, D.L. Combs, T.D. Henry, J.J. Lopez, S.G. Ellis, J.H. Yi, B.H. Annex, E.R. McCluskey, and T.F. Zioncheck A target-mediated model to describe the pharmacokinetics and hemodynamic effects of recombinant human vascular endothelial growth factor in humans Clin. Pharmacol. Ther. 72 2002 20 32
11. I. Stein, M. Neeman, D. Shweiki, A. Itin, and E. Keshet Stabilization of vascular endothelial growth factor mRNA by hypoxia and hypoglycemia and coregulation with other ischemia-induced genes Mol. Cell. Biol. 15 1995 5363 5368
12. D.H. Kempen, L. Lu, A. Heijink, T.E. Hefferan, L.B. Creemers, A. Maran, M.J. Yaszemski, and W.J. Dhert Effect of local sequential VEGF and BMP-2 delivery on ectopic and orthotopic bone regeneration Biomaterials 30 2009 2816 2825
13. F.R. Formiga, B. Pelacho, E. Garbayo, G. Abizanda, J.J. Gavira, T. Simon-Yarza, M. Mazo, E. Tamayo, C. Jauquicoa, C. Ortiz-de-Solorzano, F. Prosper, and M.J. Blanco-Prieto Sustained release of VEGF through PLGA microparticles improves vasculogenesis and tissue remodeling in an acute myocardial ischemia-reperfusion model J. Control. Release 147 2010 30 37
14. Y. Ikada, and Y. Tabata Protein release from gelatin matrices Adv. Drug Deliv. Rev. 31 1998 287 301
15. Z.S. Patel, H. Ueda, M. Yamamoto, Y. Tabata, and A.G. Mikos In vitro and in vivo release of vascular endothelial growth factor from gelatin microparticles and biodegradable composite scaffolds Pharm. Res. 25 2008 2370 2378
16. Z.S. Patel, S. Young, Y. Tabata, J.A. Jansen, M.E. Wong, and A.G. Mikos Dual delivery of an angiogenic and an osteogenic growth factor for bone regeneration in a critical size defect model Bone 43 2008 931 940
17. M. Yamamoto, Y. Ikada, and Y. Tabata Controlled release of growth factors based on biodegradation of gelatin hydrogel J. Biomater. Sci. Polym. Ed. 12 2001 77 88
18. S.C. Leeuwenburgh, J. Jo, H. Wang, M. Yamamoto, J.A. Jansen, and Y. Tabata Mineralization, biodegradation, and drug release behavior of gelatin/apatite composite microspheres for bone regeneration Biomacromolecules 11 2010 2653 2659
19. M. Yamamoto, Y. Takahashi, and Y. Tabata Controlled release by biodegradable hydrogels enhances the ectopic bone formation of bone morphogenetic protein Biomaterials 24 2003 4375 4383
20. A. Cittadini, M.G. Monti, V. Petrillo, G. Esposito, G. Imparato, A. Luciani, F. Urciuolo, E. Bobbio, C.F. Natale, L. Sacca, and P.A. Netti Complementary therapeutic effects of dual delivery of insulin-like growth factor-1 and vascular endothelial growth factor by gelatin microspheres in experimental heart failure Eur. J. Heart Fail. 13 2011 1264 1274
21. Q. Liu, S.H. Zhao, M.J. Lu, S.L. Jiang, C.W. Yan, Y. Zhang, L. Meng, Y. Tang, X.M. Meng, Y.J. Wei, L.L. Wang, H.J. Dai, and J. Xu Gelatin microspheres containing vascular endothelial growth factor enhances the efficacy of bone marrow mesenchymal stem cells transplantation in a swine model of myocardial infarction Zhonghua Xin Xue Guan Bing Za Zhi 37 2009 233 239
22. M.T. Poldervaart, H. Wang, J. van der Stok, H. Weinans, S.C. Leeuwenburgh, F.C. Oner, W.J. Dhert, and J. Alblas Sustained release of BMP-2 in bioprinted alginate for osteogenicity in mice and rats PLoS ONE 8 2013 e72610
23. N.E. Fedorovich, E. Kuipers, D. Gawlitta, W.J. Dhert, and J. Alblas Scaffold porosity and oxygenation of printed hydrogel constructs affect functionality of embedded osteogenic progenitors Tissue Eng. A 17 2011 2473 2486
24. S. Young, M. Wong, Y. Tabata, and A.G. Mikos Gelatin as a delivery vehicle for the controlled release of bioactive molecules J. Control. Release 109 2005 256 274
25. Z.S. Patel, M. Yamamoto, H. Ueda, Y. Tabata, and A.G. Mikos Biodegradable gelatin microparticles as delivery systems for the controlled release of bone morphogenetic protein-2 Acta Biomater. 4 2008 1126 1138
26. A. Bigi, G. Cojazzi, S. Panzavolta, K. Rubini, and N. Roveri Mechanical and thermal properties of gelatin films at different degrees of glutaraldehyde crosslinking Biomaterials 22 2001 763 768
27. A. Niemisto, V. Dunmire, O. Yli-Harja, W. Zhang, and I. Shmulevich Robust quantification of in vitro angiogenesis through image analysis IEEE Trans. Med. Imaging 24 2005 549 553
28. N.E. Fedorovich, H.M. Wijnberg, W.J. Dhert, and J. Alblas Distinct tissue formation by heterogeneous printing of osteo- and endothelial progenitor cells Tissue Eng. A 17 2011 2113 2121
29. W. Schuurman, V. Khristov, M.W. Pot, P.R. van Weeren, W.J. Dhert, and J. Malda Bioprinting of hybrid tissue constructs with tailorable mechanical properties Biofabrication 3 2011 021001
30. P.M. Becker, A.D. Verin, M.A. Booth, F. Liu, A. Birukova, and J.G. Garcia Differential regulation of diverse physiological responses to VEGF in pulmonary endothelial cells Am. J. Physiol. Lung Cell. Mol. Physiol. 281 2001 L1500 L1511
31. J.I. Greenberg, and D.A. Cheresh VEGF as an inhibitor of tumor vessel maturation: implications for cancer therapy Expert. Opin. Biol. Ther. 9 2009 1347 1356
32. M. Eguchi, H. Masuda, and T. Asahara Endothelial progenitor cells for postnatal vasculogenesis Clin. Exp. Nephrol. 11 2007 18 25
33. D.A. Ingram, L.E. Mead, H. Tanaka, V. Meade, A. Fenoglio, K. Mortell, K. Pollok, M.J. Ferkowicz, D. Gilley, and M.C. Yoder Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood Blood 104 2004 2752 2760
34. J.M. Melero-Martin, Z.A. Khan, A. Picard, X. Wu, S. Paruchuri, and J. Bischoff In vivo vasculogenic potential of human blood-derived endothelial progenitor cells Blood 109 2007 4761 4768
35. D.H. Kempen, L. Lu, T.E. Hefferan, L.B. Creemers, A. Maran, K.L. Classic, W.J. Dhert, and M.J. Yaszemski Retention of in vitro and in vivo BMP-2 bioactivities in sustained delivery vehicles for bone tissue engineering Biomaterials 29 2008 3245 3252
36. A.B. Ennett, D. Kaigler, and D.J. Mooney Temporally regulated delivery of VEGF in vitro and in vivo J. Biomed. Mater. Res. A 79 2006 176 184
37. J. Kleinheinz, S. Jung, K. Wermker, C. Fischer, and U. Joos Release kinetics of VEGF165 from a collagen matrix and structural matrix changes in a circulation model Head Face Med. 6 2010 17
38. R. Limame, A. Wouters, B. Pauwels, E. Fransen, M. Peeters, F. Lardon, O. De Wever, and P. Pauwels Comparative analysis of dynamic cell viability, migration and invasion assessments by novel real-time technology and classic endpoint assays PLoS ONE 7 2012 e46536
39. A. des Rieux, B. Ucakar, B.P. Mupendwa, D. Colau, O. Feron, P. Carmeliet, and V. Preat 3D systems delivering VEGF to promote angiogenesis for tissue engineering J. Control. Release 150 2011 272 278